Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Stop – Go – Stop Again – Now GO… Surprised by the No Surprises Act?

By Kirk S. Davis & Danielle C. Gordet on March 21, 2023
Email this postTweet this postLike this postShare this post on LinkedIn

We are not surprised by the continued stop-and-go regarding guidance surrounding the No Surprises Act. Most recently, a Texas court vacated portions of the No Surprises Act’s updated final rule (the final rules were discussed in our most recent blog on the subject). This created a domino effect, leading to the Departments of the Treasury, Labor, and Health and Human Services (the Departments) to inform certified independent dispute resolution (IDR) entities to halt, and then semi-halt, and then re-start payment determinations.

The U.S. District Court for the Eastern District of Texas issued a Memorandum Opinion and Order on February 6, 2023, that granted summary judgment for the plaintiffs: the Texas Medical Association, Tyler Regional Hospital, LLC, and Dr. Adam Corley. As a reminder, the latest final rules had revised the IDR process to make it clear that “certified IDR entities should [instead] select the offer that best represents the value of the item or service under dispute after considering the [qualifying payment amount] QPA and all permissible information submitted by the parties.” The Departments had hoped the latest final rule would alleviate many concerns from unhappy providers and facilities. However, the updated final rule was met with opposition from groups such as the plaintiffs in the February lawsuit.

The Texas court agreed with the plaintiffs, finding that the challenged provisions of the final rule conflict with the No Surprises Act and must be set aside. Rules implementing a statute must be consistent with the statute and cannot deviate from the concepts of the statute. The court held that the Departments abandoned the “rebuttable presumption” term, but are still privileging the QPA in favor of insurers and lowering payments to out-of-network providers. Therefore, the court determined that the proper remedy is to vacate the challenged provisions and remand to the Departments for “further consideration in light of this opinion.”

The court decision led the Departments to issue a notice on February 10, 2023, instructing certified IDR entities that they should:

  • Hold all payment determinations until further guidance is issued, and
  • Recall any payment determinations issued after February 6, 2023.

But then, (not surprisingly) the Departments revised the first notice on February 24, 2023, instructing IDR entities to:

  • Resume processing payment determinations on February 27, 2023, for disputes involving items or services furnished before October 25, 2022 (IDR entities are instructed to see here for guidance for these items or services), but
  • Hold all payment determinations that involve items or services furnished on or after October 25, 2022, until the Departments issue further guidance.

The Departments AGAIN revised the above guidance on March 17, 2023, instructing IDR entities to:

  • Resume making payment determinations that involve items or services furnished on or after October 25, 2022.

Guidance for items and services furnished on or after October 25, 2022, is posted here for certified IDR entities’ payment determinations and here for disputing parties.

For informational purposes, note that the Departments asked parties to make note of the email address, auto-reply-federalidrquestions@cms.hhs.gov, because beginning March 17, 2023, disputing parties will receive a majority of their payment determination notices from this email address for notifications being sent by the IDR portal.

We are available to assist parties seeking guidance regarding adherence to the No Surprises Act as these changes continue to develop.

Photo of Kirk S. Davis Kirk S. Davis

An accomplished litigator, Kirk Davis represents hospitals and health systems in complex regulatory compliance issues and disputes with a focus on medical malpractice and peer review hearings. Kirk has decades of experience in the peer review process and has been involved in all…

An accomplished litigator, Kirk Davis represents hospitals and health systems in complex regulatory compliance issues and disputes with a focus on medical malpractice and peer review hearings. Kirk has decades of experience in the peer review process and has been involved in all aspects of hearings, from prosecuting physicians to defending medical staff and serving as a hearing officer. He helps hospitals comply with federal and state laws by recommending peer review best practices and procedures. In addition to his work on medical malpractice matters, Kirk handles disputes between physicians in private practices and effectively resolves contentious medical practice dissolution through alternative dispute resolution. Kirk has served as an arbitrator in various healthcare-related matters and is a sought after speaker on health law topics. He is Board Certified in Health Law by The Florida Bar and recognized by Chambers USA as a leading lawyer in healthcare.

Read more about Kirk S. DavisEmail
Show more Show less
Photo of Danielle C. Gordet Danielle C. Gordet

Danielle Gordet focuses her practice on healthcare, including healthcare compliance, conflicts of interest, scope of practice issues, physician contracting, and regulations. Her ability to identify, investigate, and resolve complex issues in collaboration with healthcare administrators allows her to provide them with effective counsel…

Danielle Gordet focuses her practice on healthcare, including healthcare compliance, conflicts of interest, scope of practice issues, physician contracting, and regulations. Her ability to identify, investigate, and resolve complex issues in collaboration with healthcare administrators allows her to provide them with effective counsel in developing policies and procedures which reduce the risk of inappropriate conduct and prevent non-compliance. She provides expertise on federal and state healthcare statutory and regulatory issues, including adherence to the Stark Law, the Anti-Kickback Statute, and licensure compliance. In addition, Danielle assists manufacturers of U.S. Food and Drug Administration (FDA) regulated products in obtaining necessary FDA clearances for their devices. Danielle works with healthcare administrators on resolving a variety of legal matters, including issues surrounding hospital bylaws, licensure and credentialing, telemedicine, codes of conduct, and Emergency Medical Treatment and Labor Act. On behalf of healthcare providers, she negotiates and drafts contractual agreements including medical directorships, physician employment, clinical trials, and consulting arrangements.

Read more about Danielle C. GordetEmail
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Rx
  • Organization:
    Akerman LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo